Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $170M (100.0% shares, 0.0% debt)

Holdings (29)

— SAGE THERAPEUTICS INC 10.7%

Value $18.12M Shares 255,000 Est. Cost $47.85 Unrealized —

— FOUNDATION MEDICINE INC 9.1%

Value $15.48M Shares 480,000 Est. Cost $18.96 Unrealized —

— LOXO ONCOLOGY INC 8.9%

Value $15.15M Shares 360,000 Est. Cost $28.44 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 8.2%

Value $13.87M Shares 237,500 Est. Cost $51.75 Unrealized -7.4%

— BLUEPRINT MEDICINES CORP 6.9%

Value $11.78M Shares 294,500 Est. Cost $28.38 Unrealized —

EVH EVOLENT HEALTH INC 6.8%

Value $11.6M Shares 520,000 Est. Cost $18.09 Unrealized +6.1%

— EPIZYME INC 4.9%

Value $8.318M Shares 485,000 Est. Cost $15.65 Unrealized —

— SPARK THERAPEUTICS INC 4.2%

Value $7.201M Shares 135,000 Est. Cost $45.28 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 3.9%

Value $6.62M Shares 500,000 Est. Cost $15.72 Unrealized —

— GENMARK DIAGNOSTICS INC 3.0%

Value $5.128M Shares 400,000 Est. Cost $9.74 Unrealized —

— AUDENTES THERAPEUTICS INC 2.6%

Value $4.43M Shares 260,000 Est. Cost $17.04 Unrealized —

SGMO SANGAMO THERAPEUTICS INC 2.6%

Value $4.42M Shares 850,000 Est. Cost $4.01 Unrealized 0.0%

MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.3%

Value $3.931M Shares 310,000 Est. Cost $12.72 Unrealized -6.8%

— GLOBAL BLOOD THERAPEUTICS IN 2.2%

Value $3.74M Shares 101,500 Est. Cost $17.96 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 2.1%

Value $3.619M Shares 700,000 Est. Cost $4.89 Unrealized 0.0%

— MYOKARDIA INC 2.1%

Value $3.485M Shares 265,000 Est. Cost $13.62 Unrealized —

— KITE PHARMA INC 2.0%

Value $3.336M Shares 42,500 Est. Cost $52.57 Unrealized —

CDXS CODEXIS INC 1.9%

Value $3.24M Shares 675,000 Est. Cost $4.56 Unrealized 0.0%

— AMYRIS INC 1.9%

Value $3.18M Shares 6,000,000 Est. Cost $0.64 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.8%

Value $3.065M Shares 177,500 Est. Cost $15.07 Unrealized -12.7%

EDIT EDITAS MEDICINE INC 1.8%

Value $2.976M Shares 133,333 Est. Cost $20.61 Unrealized +0.6%

— SYROS PHARMACEUTICALS INC 1.7%

Value $2.902M Shares 182,141 Est. Cost $13.81 Unrealized —

— JOUNCE THERAPEUTICS INC 1.7%

Value $2.859M Shares 130,000 Est. Cost $21.99 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 1.7%

Value $2.819M Shares 55,000 Est. Cost $61.19 Unrealized -24.5%

— TESARO INC 1.6%

Value $2.693M Shares 17,500 Est. Cost $153.89 Unrealized —

— BLUEBIRD BIO INC 1.4%

Value $2.318M Shares 25,500 Est. Cost $60.64 Unrealized —

— CLOVIS ONCOLOGY INC 0.9%

Value $1.464M Shares 23,000 Est. Cost $63.65 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.7%

Value $1.134M Shares 420,000 Est. Cost $2.70 Unrealized —

— CURIS INC 0.4%

Value $639K Shares 230,000 Est. Cost $2.78 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SAGE THERAPEUTICS INC	255,000	$18.12M	10.7%	$47.85	—	COM	78667J108
—	FOUNDATION MEDICINE INC	480,000	$15.48M	9.1%	$18.96	—	COM	350465100
—	LOXO ONCOLOGY INC	360,000	$15.15M	8.9%	$28.44	—	COM	548862101
AGIO	AGIOS PHARMACEUTICALS INC	237,500	$13.87M	8.2%	$51.75	-7.4%	COM	00847X104
—	BLUEPRINT MEDICINES CORP	294,500	$11.78M	6.9%	$28.38	—	COM	09627Y109
EVH	EVOLENT HEALTH INC	520,000	$11.6M	6.8%	$18.09	+6.1%	CL A	30050B101
—	EPIZYME INC	485,000	$8.318M	4.9%	$15.65	—	COM	29428V104
—	SPARK THERAPEUTICS INC	135,000	$7.201M	4.2%	$45.28	—	COM	84652J103
VYGR	VOYAGER THERAPEUTICS INC	500,000	$6.62M	3.9%	$15.72	—	COM	92915B106
—	GENMARK DIAGNOSTICS INC	400,000	$5.128M	3.0%	$9.74	—	COM	372309104
—	AUDENTES THERAPEUTICS INC	260,000	$4.43M	2.6%	$17.04	—	COM	05070R104
SGMO	SANGAMO THERAPEUTICS INC	850,000	$4.42M	2.6%	$4.01	0.0%	COM	800677106
MDRX	ALLSCRIPTS HEALTHCARE SOLUTN	310,000	$3.931M	2.3%	$12.72	-6.8%	COM	01988P108
—	GLOBAL BLOOD THERAPEUTICS IN	101,500	$3.74M	2.2%	$17.96	—	COM	37890U108
PACB	PACIFIC BIOSCIENCES CALIF IN	700,000	$3.619M	2.1%	$4.89	0.0%	COM	69404D108
—	MYOKARDIA INC	265,000	$3.485M	2.1%	$13.62	—	COM	62857M105
—	KITE PHARMA INC	42,500	$3.336M	2.0%	$52.57	—	COM	49803L109
CDXS	CODEXIS INC	675,000	$3.24M	1.9%	$4.56	0.0%	COM	192005106
—	AMYRIS INC	6,000,000	$3.18M	1.9%	$0.64	—	COM	03236M101
CTMX	CYTOMX THERAPEUTICS INC	177,500	$3.065M	1.8%	$15.07	-12.7%	COM	23284F105
EDIT	EDITAS MEDICINE INC	133,333	$2.976M	1.8%	$20.61	+0.6%	COM	28106W103
—	SYROS PHARMACEUTICALS INC	182,141	$2.902M	1.7%	$13.81	—	COM	87184Q107
—	JOUNCE THERAPEUTICS INC	130,000	$2.859M	1.7%	$21.99	—	COM	481116101
ALNY	ALNYLAM PHARMACEUTICALS INC	55,000	$2.819M	1.7%	$61.19	-24.5%	COM	02043Q107
—	TESARO INC	17,500	$2.693M	1.6%	$153.89	—	COM	881569107
—	BLUEBIRD BIO INC	25,500	$2.318M	1.4%	$60.64	—	COM	09609G100
—	CLOVIS ONCOLOGY INC	23,000	$1.464M	0.9%	$63.65	—	COM	189464100
—	ADVERUM BIOTECHNOLOGIES INC	420,000	$1.134M	0.7%	$2.70	—	COM	00773U108
—	CURIS INC	230,000	$639K	0.4%	$2.78	—	COM	231269101